Alibaba vs Amgen: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Alibaba and Amgen side by side

1. 1980Amgen

   Applied Molecular Genetics is incorporated

   Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.

2. 1983Amgen

   Nasdaq listing and the erythropoietin clone

   Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.

3. 1984Amgen

   Kirin-Amgen joint venture formed

   Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.

4. 1985Amgen

   G-CSF cloned, leading to Neupogen

   While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.

5. 1989Amgen

   FDA approves Epogen

   The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.

6. 1991Amgen

   Neupogen approved, giving Amgen a second franchise

   The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.

7. 1991Amgen

   Amgen wins the erythropoietin patent fight

   On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.

8. 1999Alibaba

   Alibaba.com Launched

   Jack Ma and 17 co-founders launch Alibaba.com from a Hangzhou apartment with $60,000 in pooled savings, creating a B2B online marketplace connecting Chinese manufacturers with international buyers.

9. 1999Alibaba

   First Major Investment from SoftBank

   Masayoshi Son invests $20 million in Alibaba in a meeting reportedly lasting five minutes, alongside $5 million from Goldman Sachs, providing survival capital through the imminent dot-com crash.

10. 2001Alibaba

    Gold Supplier Program Launch

    Alibaba launches the Gold Supplier verified membership program at $3,000 per year, generating approximately $10 million in first-year revenue and proving the B2B marketplace model's commercial viability.

11. 2001Amgen

    FDA approves Aranesp, the longer-acting EPO

    Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.

12. 2002Amgen

    US$16 billion Immunex acquisition brings Enbrel in-house

    Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.

13. 2003Alibaba

    Taobao Launches to Challenge eBay

    Alibaba secretly develops and launches Taobao, a consumer-to-consumer marketplace offered free to both buyers and sellers, directly targeting eBay's Chinese market position. Within three years, Taobao surpasses eBay's Chinese market share.

14. 2004Alibaba

    Alipay Escrow Service Created

    Alibaba creates Alipay as a payment escrow solution for Taobao transactions, holding buyer funds until delivery confirmation before releasing payment to sellers solving the trust barrier that was limiting online commerce adoption.

15. 2008Alibaba

    Tmall (Taobao Mall) Launch

    Alibaba launches a premium B2C marketplace initially called Taobao Mall (later rebranded Tmall), allowing established brands to operate official storefronts with higher trust credentials and enabling Alibaba to serve the premium consumer segment.

16. 2009Alibaba

    Alibaba Cloud Founded

    Alibaba launches Alibaba Cloud (Aliyun) as a cloud computing business, a decade ahead of many enterprise adoption cycles, positioning it to become Asia Pacific's dominant cloud provider.

17. 2010Amgen

    Prolia and XGEVA create the bone health franchise

    The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.

18. 2011Alibaba

    First Singles' Day Shopping Festival

    Alibaba transforms the informal 'Singles' Day' celebration on November 11 into a promotional shopping event on Taobao and Tmall, generating ~$130 million (936 million yuan) in sales a figure that would grow more than 100-fold in subsequent years.

19. 2014Alibaba

    Record-Breaking NYSE IPO

    Alibaba completes its initial public offering on the New York Stock Exchange on September 19, 2014, raising $25 billion the largest IPO in US stock market history at that time at a valuation of approximately $168 billion.

20. 2019Alibaba

    Dual Listing on Hong Kong Stock Exchange

    Alibaba completes a secondary listing on the Hong Kong Stock Exchange, raising an additional $13 billion and broadening its investor base among Asian institutional and retail investors, reducing dependence on US capital markets.

21. 2019Amgen

    US$13.4 billion purchase of Otezla from Celgene

    Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.

22. 2020Amgen

    Amgen joins the Dow Jones Industrial Average

    Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.

23. 2021Alibaba

    Record Antitrust Fine

    Chinese regulators impose a 18.23 billion yuan ($2.8 billion USD) antitrust fine on Alibaba following a months-long investigation into its 'choose one from two' exclusivity practices at the time, the largest antitrust fine in Chinese regulatory history.

24. 2023Alibaba

    Six-Business-Unit Restructuring Announced

    Alibaba announces its most significant organizational restructuring, dividing the company into six independent business units each with its own CEO and board: Taobao Tmall Group, Cloud Intelligence Group, Alibaba International Digital Commerce Group, Cainiao S…

25. 2023Amgen

    US$27.8 billion Horizon Therapeutics acquisition closes

    Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.

26. 2024Amgen

    Imdelltra becomes the first T-cell engager for small cell lung cancer

    The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.

27. 2025Amgen

    VESALIUS-CV extends the Repatha case to primary prevention

    In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.

28. 2026Amgen

    Medicare price setting reaches Enbrel and Otezla

    Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.

Acquisitions

Questions about Alibaba vs Amgen